Initial Treatment of Advanced Ovarian Carcinoma Carboplatin Injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of Carboplatin Injection and cyclophosphamide.
From the U.S. FDA-approved label for Carboplatin. Full label: DailyMed.
Initial Treatment of Advanced Ovarian Carcinoma Carboplatin Injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of Carboplatin Injection and cyclophosphamide. Two randomized controlled studies conducted by the NCIC and SWOG with carboplatin versus cisplatin, both in combination with cyclophosphamide, have demonstrated equivalent overall survival between the two groups (see CLINICAL STUDIES ). There is limited statistical power to demonstrate equivalence in overall pathologic complete response rates and long-term survival (≥ 3 years) because of the small number of patients with these outcomes: the small number of patients with residual tumor <2 cm after initial surgery also limits the statistical power to demonstrate equivalence in this subgroup. Secondary Treatment of Advanced Ovarian Carcinoma Carboplatin Injection is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin.
From the U.S. FDA-approved label for Carboplatin. Full label: DailyMed.
Single Agent Therapy Carboplatin Injection, as a single agent, has been shown to be effective in patients with recurrent ovarian carcinoma at a dosage of 360 mg/m 2 IV on day 1 every 4 weeks (alternatively see Formula Dosing ). Combination Therapy with Cyclophosphamide In the chemotherapy of advanced ovarian cancer, an effective combination for previously untreated patients consists of: Carboplatin Injection - 300 mg/m 2 IV on day 1 every four weeks for six cycles (alternatively see Formula Dosing ). Cyclophosphamide - 600 mg/m 2 IV on day 1 every four weeks for six cycles.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Carboplatin Injection is contraindicated in patients with a history of severe allergic reactions to cisplatin or other platinum-containing compounds. Carboplatin Injection should not be employed in patients with severe bone marrow depression or significant bleeding.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Bone marrow suppression (leukopenia, neutropenia, and thrombocytopenia) is dose-dependent and is also the dose-limiting toxicity. Peripheral blood counts should be frequently monitored during carboplatin treatment and, when appropriate, until recovery is achieved. Median nadir occurs at day 21 in patients receiving single agent carboplatin. In general, single intermittent courses of carboplatin should not be repeated until leukocyte, neutrophil, and platelet counts have recovered.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
For a comparison of toxicities when carboplatin or cisplatin was given in combination with cyclophosphamide, see CLINICAL STUDIES: Use with Cyclophosphamide for Initial Treatment of Ovarian Cancer: Comparative Toxicity.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
68 products from 37 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Carboplatin 150mg Injection | Carboplatin (150mg) | Pfizer Ltd. | |
| Carboplatin 450mg Injection | Carboplatin (450mg) | Pfizer Ltd. | |
| Carbotin 150 150mg Injection | Carboplatin (150mg) | Getwell Pharmaceuticals | |
| Carbotin 450 450mg Injection | Carboplatin (450mg) | Getwell Pharmaceuticals | |
| Cytocarb 150 150mg Injection | Carboplatin (150mg) | Cipla Ltd. | |
| Cytocarb 450 450mg Injection | Carboplatin (450mg) | Cipla Ltd. | |
| Kemocarb 150mg Injection | Carboplatin (150mg) | Fresenius Kabi pharmaceuticals | |
| Kemocarb 450mg Injection | Carboplatin (450mg) | Fresenius Kabi pharmaceuticals | |
| Acoticyt 150mg Injection | Carboplatin (150mg) | Accord Pharmaceuticals | vial of 1 Injection |
| Adcarb 150mg Injection | Carboplatin (150mg) | Adley Formulations | vial of 15 ml Injection |
| Adcarb 450mg Injection | Carboplatin (450mg) | Adley Formulations | vial of 45 ml Injection |
| Alcarb 150mg Injection | Carboplatin (150mg) | Axiommax Oncology Pvt Ltd | vial of 15 ml Injection |
| Alcarb 450 Injection | Carboplatin (450mg) | Axiommax Oncology Pvt Ltd | vial of 45 ml Injection |
| Biocarb 150mg Injection | Carboplatin (150mg) | Biochem Pharmaceutical Industries | vial of 1 Injection |
| Biocarb 450mg Injection | Carboplatin (450mg) | Biochem Pharmaceutical Industries | vial of 1 Injection |
| Blastocarb 10mg Injection | Carboplatin (10mg) | Lemery | vial of 15 ml Injection |
| Blastoplatin 150mg Injection | Carboplatin (150mg) | Chandra Bhagat Pharma Pvt Ltd | vial of 15 ml Injection |
| Blastoplatin 450mg Injection | Carboplatin (450mg) | Chandra Bhagat Pharma Pvt Ltd | vial of 45 ml Injection |
| Caboo 150mg Injection | Carboplatin (150mg) | Neon Laboratories Ltd | vial of 15 ml Injection |
| Caboo 450mg Injection | Carboplatin (450mg) | Neon Laboratories Ltd | vial of 45 ml Injection |
| Carb DNA 450mg Injection | Carboplatin (450mg) | Metta Life Sciences Private Limited | vial of 1 Injection |
| Carb-DNA Injection | Carboplatin (150mg) | Metta Life Sciences Private Limited | vial of 15 ml Injection |
| Carbocare 150mg Injection | Carboplatin (150mg) | Dr Derma Expert Skin Care & Cure | vial of 15 ml Injection |
| Carbocare 450mg Injection | Carboplatin (450mg) | Dr Derma Expert Skin Care & Cure | vial of 45 ml Injection |
| Carbokem Nova 450mg Injection | Carboplatin (450mg) | Alkem Laboratories Ltd | vial of 45 ml Injection |
| Carbokem Novo 150mg Injection | Carboplatin (150mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Carbokem Novo 600mg Injection | Carboplatin (600mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Carbomax 150mg Injection | Carboplatin (150mg) | GLS Pharma Ltd. | vial of 15 ml Injection |
| Carbomax 450mg Injection | Carboplatin (450mg) | GLS Pharma Ltd. | vial of 45 ml Injection |
| Carbopa 150mg Injection | Carboplatin (150mg) | Intas Pharmaceuticals Ltd | vial of 1 Injection |
Showing 30 of 68 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Unopened vials of Carboplatin Injection are stable to the date indicated on the package when stored at 25°C (77°F); excursions permitted from 15°–30°C (59°–86°F). Protect from light. Carboplatin Injection multiple-dose vials maintain microbial, chemical, and physical stability for up to 14 days at 25°C following multiple needle entries.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.